Live Breaking News & Updates on ஜ்ப் இரசாயனங்கள் மருந்துகள் லிமிடெட்

Healthcare shares slide

Healthcare shares slide
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Novartis-india-ltd , Gland-pharma-ltd , Aurobindo-pharma-ltd , Fortis-healthcare-ltd , Suven-pharmaceuticals-ltd , Hikal-ltd , Morepen-laboratories-ltd , Jb-chemicals-pharmaceuticals-ltd , Lincoln-pharmaceuticals-ltd , Albert-david-ltd , Fermenta-biotech-ltd

Healthcare shares gain

Healthcare stocks were trading in the positive zone, with the S&P BSE Healthcare index rising 183.06 points or 0.71% at 25936.52 at 09:50 IST.
Among the components of the S&P BSE Healthcare index, IOL Chemicals & Pharmaceuticals Ltd (up 7.97%), J B Chemicals & Pharmaceuticals Ltd (up 7.49%),Caplin Point Laboratories Ltd (up 3.89%),Aurobindo Pharma Ltd (up 3.65%),Sun Pharma Advanced Research Company Ltd (up 3.18%), were the top gainers. Among the other gainers were Shalby Ltd (up 2.82%), Strides Pharma Science Ltd (up 2.72%), Granules India Ltd (up 2.56%), Unichem Laboratories Ltd (up 2.44%), and Aarti Drugs Ltd (up 2.24%).
On the other hand, Lincoln Pharmaceuticals Ltd (down 1.58%), Neuland Laboratories Ltd (down 1.32%), and Wockhardt Ltd (down 0.87%) moved lower.

India , Aurobindo-pharma-ltd , Unichem-laboratories-ltd , Jb-chemicals-pharmaceuticals-ltd , Caplin-point-laboratories-ltd , Lincoln-pharmaceuticals-ltd , Neuland-laboratories-ltd , Granules-india-ltd , Shalby-ltd , Strides-pharma-science-ltd , Aarti-drugs-ltd

Healthcare shares fall

Healthcare shares fall
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Novartis-india-ltd , Max-healthcare-institute-ltd , Alkem-laboratories-ltd , Apollo-hospitals-enterprise-ltd , Healthcare-global-enterprises-ltd , Dishman-carbogen-amcis-ltd , Divis-laboratories-ltd , Marksans-pharma-ltd , Hikal-ltd , Jb-chemicals-pharmaceuticals-ltd , Lincoln-pharmaceuticals-ltd

JB Chemicals & Pharmaceuticals Ltd Board approves final dividend of Rs. 8

JB Chemicals & Pharmaceuticals Ltd Board approves final dividend of Rs. 8
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Jb-chemicals-pharmaceuticals-ltd-board , Jb-chemicals-pharmaceuticals-ltd , Pharmaceuticals-ltd-board , Time-zone , Pharmaceuticals-ltd , ஜ்ப்-இரசாயனங்கள்-மருந்துகள்-லிமிடெட்-பலகை , ஜ்ப்-இரசாயனங்கள்-மருந்துகள்-லிமிடெட் , மருந்துகள்-லிமிடெட்-பலகை , நேரம்-ஸோந் , மருந்துகள்-லிமிடெட் ,

JB Chemical share price: Buy J B Chemicals, target price Rs 1520: IIFL

Synopsis
J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 11387.90 Crore) operating in Pharmaceuticals sector.
Promoters held 55.91 per cent stake in the company as of March 31, 2020, while FIIs held 7.18 per cent, DIIs 14.35 per cent and public and other 22.35 per cent.
IIFL has buy call on J B Chemicals & Pharmaceuticals with a target price of Rs 1520. The current market price of J B Chemicals & Pharmaceuticals Ltd. is Rs 1473.35.
J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 11387.90 Crore) operating in Pharmaceuticals sector.

Jb-chemicals-pharmaceuticals , Jb-chemicals-pharmaceuticals-ltd , Pharmaceuticals-ltd , Mid-cap , Consolidated-total-income , Total-income , ஜ்ப்-இரசாயனங்கள்-மருந்துகள் , ஜ்ப்-இரசாயனங்கள்-மருந்துகள்-லிமிடெட் , மருந்துகள்-லிமிடெட் , நடுவில்-தொப்பி , தொகுக்கப்பட்டு-மொத்தம்-வருமானம்

J B Chemicals & Pharmaceuticals Share Price : Live NSE/BSE Stock Price Today

J B Chemicals & Pharmaceuticals Share Price : Live NSE/BSE Stock Price Today
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Belapur-ankleshwar-panoli , Jb-chemicals-pharmaceuticals , Jb-chemicals-pharmaceuticals-ltd , Thane-belapur-ankleshwar-panoli , ஜ்ப்-இரசாயனங்கள்-மருந்துகள் , ஜ்ப்-இரசாயனங்கள்-மருந்துகள்-லிமிடெட் ,

J.B. Chemicals & Pharmaceuticals Ltd. enters the Nephrology segment in India

J.B. Chemicals & Pharmaceuticals Ltd. enters the Nephrology segment in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

India , Nikhil-chopra , Jb-chemicals-pharmaceuticals , Jb-chemicals-pharmaceuticals-ltd , Time-zone , Pharmaceuticals-ltd , Chronic-kidney , Chronic-kidney-disease , Kidney-disease , Global-disease-burden , Pharmaceuticals-limited

UBS Expects Record IPO Year for India Despite Covid-19 Crisis

(Bloomberg) -- India’s sharp surge in Covid-19 cases will not prevent the country’s markets from setting a record for initial public offerings in 2021, as a cohort of technology companies make their much-anticipated debuts later in the year, according to UBS Group AG. Last year companies amassed $4.6 billion from IPOs, according to data compiled by Bloomberg, and Anuj Kapoor, head of investment banking at UBS India, believes the figure will be easily eclipsed. “I would say we will surpass twice the money we raised in 2020 through IPOs,” Kapoor said. Before the arrival of the coronavirus pandemic’s second wave, India’s markets were full of optimism. So far in 2021, IPOs in India have raised nearly $3 billion, the best start to the year since 2018, the data show. The activity was aided by ample liquidity, with foreign investors as well as retail stock-pickers looking for new ideas to invest in, Kapoor said. Read More: SPACs Look to India for Next Wave of Targets, Nomura Says The latest outbreak of Covid-19 cases has had a serious impact on the equities market, and there has been a decoupling of Indian versus global markets since March, Kapoor said. The benchmark Sensex index has risen 2.2% this year, compared to the 9.3% gain year to date in the MSCI World index. Overseas investors sold $1.4 billion worth of Indian stocks in the month to April 29, the biggest monthly outflow since March last year when the nation imposed one of the strictest lockdowns in the world to curb the spread of the pandemic. “We will see a few more tough weeks ahead before Covid-19 plateaus and starts declining,” said Kapoor, who is also on the board of UBS India. “Hopefully, this should not linger beyond June.” Kapoor expects tech companies to start hitting the market in the second half of the year. He predicts fewer than five will list this year, however that figure could more than double in 2022. Online food delivery startup Zomato Ltd. recently filed its initial prospectus with the regulator for an IPO that could raise as much as 82.5 billion rupees ($1.1 billion). Other tech-based businesses waiting in the wings include cosmetics retailer Nykaa E-Retail Pvt and insurance aggregator Policybazaar, Bloomberg News has reported. Read More: IPO Boom Prompts ICICI to Hire More Investment Bankers On the mergers and acquisitions front, Kapoor sees more deal activity from local companies and foreign players buying Indian firms than in domestic firms targeting assets overseas. Global private equity funds have a strong interest in the health-care and pharmaceutical sectors, he said. Last year saw KKR & Co. buy a majority stake in J.B. Chemicals & Pharmaceuticals Ltd. in a $371.3 million deal that completed in November. A month earlier, Carlyle Group Inc. closed a transaction to acquire a 20% interest in Piramal Pharma Ltd. for $466 million. Locally, some of the largest investors in tech companies will push the firms toward consolidation. “We are going to see this theme play out as business models mature,” he said. He also sees combinations occurring in areas such as financial services. Kapoor’s bullishness stems from his unit’s performance in 2020, UBS’s best year ever in India by revenue, driven primarily by equities activity, he said. The firm added new junior banker roles in March, and will recruit talent judiciously, he said. “This year we will have a healthy mix of capital markets and M&A,” he said. “2021 should be better for deal activity than 2020.” ©2021 Bloomberg L.P.

India , Anuj-kapoor , Bloomberg , Zomato-ltd , Piramal-pharma-ltd , Carlyle-group-inc , Jb-chemicals-pharmaceuticals-ltd , Next-wave , Nykaae-retail-pvt , Bloomberg-news , Hire-more-investment , Carlyle-group

Healthcare stocks slide

Read more about Healthcare stocks slide on Business Standard. Healthcare stocks were trading in red, with the S&P BSE Healthcare index decreasing 229.34 points or 1.04% at 21803.98 at 13:48 IST.

India , Aurobindo-pharma-ltd , Fortis-healthcare-ltd , Healthcare-global-enterprises-ltd , Dr-reddys-laboratories-ltd , Jb-chemicals-pharmaceuticals-ltd , Granules-india-ltd , Natco-pharma-ltd , Dr-lal-pathlabs-ltd , Fermenta-biotech-ltd , Aarti-drugs-ltd

Volumes spurt at Allcargo Logistics Ltd counter

Allcargo Logistics Ltd registered volume of 24.67 lakh shares by 10:48 IST on BSE, a 155.45 fold spurt over two-week average daily volume of 15871 shares
Westlife Development Ltd, J B Chemicals & Pharmaceuticals Ltd, Suprajit Engineering Ltd, Bata India Ltd are among the other stocks to see a surge in volumes on BSE today, 11 February 2021.
Allcargo Logistics Ltd registered volume of 24.67 lakh shares by 10:48 IST on BSE, a 155.45 fold spurt over two-week average daily volume of 15871 shares. The stock rose 1.06% to Rs.133.50. Volumes stood at 18844 shares in the last session.
Westlife Development Ltd registered volume of 8.73 lakh shares by 10:48 IST on BSE, a 143.67 fold spurt over two-week average daily volume of 6080 shares. The stock slipped 0.50% to Rs.460.30. Volumes stood at 6677 shares in the last session.

Bata-india-ltd , Allcargo-logistics-ltd , Jb-chemicals-pharmaceuticals-ltd , Suprajit-engineering-ltd , Westlife-development-ltd , Development-ltd , Pharmaceuticals-ltd , Logistics-ltd , Engineering-ltd , India-ltd , Capital-market